The CMS' mandatory VBC programs have sparked a heated debate in the healthcare industry, with a recent study shedding light on the substantial administrative costs they impose on hospitals. This analysis, published in JAMA Health Forum, delves into the financial implications of participation in three key programs: Hospital Value-Based Purchasing (HVBP), Hospital Readmissions Reduction Program (HRRP), and Hospital-Acquired Condition Reduction Program (HACRP). The study's findings are eye-opening, revealing a significant increase in administrative costs for hospitals that engage in these programs.
The research, conducted by the Brown University School of Public Health, analyzed Medicare cost report data from 2008 to 2020, covering over 2,800 hospitals. The results are staggering, with an aggregated additional cost of more than $3 billion for hospitals participating in the mandatory programs. This translates to hundreds of thousands to millions of additional annual costs per facility, depending on the hospital type and programs involved. The study highlights that these hospitals had to expand their staffing and workflows to meet the stringent program requirements, including reporting, care coordination, clinical documentation, and risk adjustment.
What's more intriguing is the comparison made between participating and non-participating hospitals. The analysis revealed that annual administrative cost increases were substantial, ranging from $1.23 million for general acute hospitals to $930,000 for critical access hospitals and $650,000 for long-term acute care hospitals. When it comes to the Comprehensive Care for Joint Replacement (CJR) model, participation was associated with an annual increase of $1.4 million per hospital. The study's findings are even more striking when considering hospitals that participated in all four models, with annual per-hospital administrative cost increases ranging from $2.78 million to $2.06 million compared to non-participating hospitals.
The researchers also noted that these increases were consistent across various salary-related administrative cost categories, whereas nonsalary-related costs showed larger increases but were not statistically significant. Interestingly, the study found that hospitals with higher Medicare Advantage penetration experienced even greater administrative cost increases, raising concerns about CMS' spending efficiency analyses. The authors emphasize the need for policymakers to carefully consider the trade-offs between cost, quality, and access when implementing value-based payment models.
The CMS has been promoting the CJR model as a success story, claiming over $100 million in savings while maintaining patient care quality. However, hospital industry associations have expressed their concerns. They argue that mandatory participation in the CJR-X Model could pose significant challenges, especially for smaller hospitals that lack the scale or financial capacity to invest in care redesign. These associations advocate for a phased or voluntary approach to help hospitals adapt, citing complex requirements and overlapping accountability obligations with other programs.
In conclusion, the study's findings highlight the substantial administrative costs associated with CMS' mandatory VBC programs. While these programs aim to improve healthcare quality, the financial burden on hospitals is undeniable. Policymakers must carefully weigh the benefits against the challenges and consider alternative approaches to ensure a sustainable and equitable healthcare system. This debate underscores the complexity of healthcare reform and the need for comprehensive solutions that address the concerns of all stakeholders.
